Cheema Huma Arshad, Malik Hassan Suleman, Waheed Nadia, Mushtaq Iqra, Fayyaz Zafar, Anjum Mohammad Nadeem
Department of Pediatric Gastroenterology and Hepatology, The Children's Hospital and The Institute of Child Health, Lahore.
J Coll Physicians Surg Pak. 2018 May;28(5):406-408. doi: 10.29271/jcpsp.2018.05.406.
Berardinelli-Seip congenital lipodystrophy (BSCL) syndrome is a rare genetic disorder caused by dysregulation of glycemic and lipid metabolism. We report five BSCL cases with typical clinical pictures and complications. These, to the best of our knowledge, represent the first case series from Pakistan. BSCL is characterized by marked atrophy of adipose tissue, acromegaly, acanthosis nigricans and tall stature. We could not perform genetics studies in any patient owing to non-availability of genetic laboratory in Pakistan. All the cases presented hypertriglyceridemia. One case developed hyperinsulinism controlled with metformin. There is no curative treatment and the current approach is low-fat diet and management of insulin resistance and diabetes. Recently published studies showed that leptin-replacement therapy is promising in the metabolic correction of complications of BSCL. This highlights the importance of further research in BSCL treatment.
贝拉尔迪内利-塞普先天性脂肪营养不良(BSCL)综合征是一种由血糖和脂质代谢失调引起的罕见遗传性疾病。我们报告了5例具有典型临床表现和并发症的BSCL病例。据我们所知,这些是来自巴基斯坦的首个病例系列。BSCL的特征是脂肪组织明显萎缩、肢端肥大症、黑棘皮病和身材高大。由于巴基斯坦没有基因实验室,我们无法对任何患者进行遗传学研究。所有病例均出现高甘油三酯血症。1例患者出现高胰岛素血症,通过二甲双胍得以控制。目前尚无治愈性治疗方法,当前的治疗方法是低脂饮食以及对胰岛素抵抗和糖尿病进行管理。最近发表的研究表明,瘦素替代疗法在BSCL并发症的代谢纠正方面很有前景。这凸显了对BSCL治疗进行进一步研究的重要性。